The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer (Q42157592)
scientific article
Language:
Current Data About The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer
(P31) (Q13442814)
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P304) 351-356
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P433) 3-4
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P478) 8
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P577) Monday, January 1, 1990
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P1433) (Q325953)
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P1476) "The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer" (language: en)
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

(P2093) Baumann M
(P1545) 1
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

Kappl A
(P1545) 2
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

Lang T
(P1545) 3
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

Brand K
(P1545) 4
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

Siegfried W
(P1545) 5
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

Paterok E
(P1545) 6
(P248)
(P698) 2207761
(P813) Tuesday, October 17, 2017

other details
description scientific article

External Links
(P356) 10.3109/07357909009012053
(P698) 2207761